← Leaderboards
Lawrence S Honig
Neurokine Therapeutics, Llc
$14,558,257
Attributed
$18,265,250
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$18,265,250 · 8
By mechanism
P50$10,566,451 · 4
U01$4,520,736 · 1
R44$2,893,251 · 1
R01$262,877 · 1
M01$21,935 · 1
Top collaborators
- Karen S Marder5 shared
- Jeffrey Pelletier2 shared
- Wayne F Anderson1 shared
Most similar at Neurokine Therapeutics, Llc
Same institution · by research overlap
- Jeffrey Pelletier$1,196,626
- Wayne F Anderson$250,000
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBrainUniversitiesS DiseaseBiologicalGeneticBrain TissueSamplingAutopsyAgingEvaluationEnrollmentDementiaData SetResourcesSitePharmaceutical PreparationsPlasmaClinical ResearchImpaired CognitionClinical TrialsSymposiumTissuesPathology
Grant awards (31)
Development of a stress kinase inhibitor therapeutic candidate for Alzheimer's Disease and related dementia$1,218,076
R44 · FY2023 · AG
Development of a stress kinase inhibitor therapeutic candidate for Alzheimer's Disease and related dementia$1,175,175
R44 · FY2021 · AG
Targeting Lewy Body Specific Pathology Using Biomarkers$907,896
U01 · FY2020 · NS
Development of a stress kinase inhibitor therapeutic candidate for Alzheimer's Disease and related dementia$500,000
R44 · FY2020 · AG
Targeting Lewy Body Specific Pathology Using Biomarkers$1,044,669
U01 · FY2019 · NS
Clinical Core$793,886
P50 · FY2019 · AG · contact PI
Satellite Diagnostic and Treatment Clinic Core$67,440
P50 · FY2019 · AG · contact PI
Targeting Lewy Body Specific Pathology Using Biomarkers$950,555
U01 · FY2018 · NS
Clinical Core$799,033
P50 · FY2018 · AG · contact PI
Satellite Diagnostic and Treatment Clinic Core$67,878
P50 · FY2018 · AG · contact PI
Targeting Lewy Body Specific Pathology Using Biomarkers$844,960
U01 · FY2017 · NS
Clinical Core$793,888
P50 · FY2017 · AG · contact PI
Satellite Diagnostic and Treatment Clinic Core$67,440
P50 · FY2017 · AG · contact PI
Clinical Core$793,886
P50 · FY2016 · AG · contact PI
Targeting Lewy Body Specific Pathology Using Biomarkers$772,656
U01 · FY2016 · NS
Satellite Diagnostic and Treatment Clinic Core$67,440
P50 · FY2016 · AG · contact PI
Clinical Core$793,886
P50 · FY2015 · AG · contact PI
Satellite Diagnostic and Treatment Clinic Core$67,440
P50 · FY2015 · AG · contact PI
CLINICAL CORE$659,896
P50 · FY2014 · AG · contact PI
CLINICAL CORE$611,207
P50 · FY2013 · AG · contact PI
CLINICAL CORE$697,004
P50 · FY2012 · AG · contact PI
CLINICAL CORE$694,489
P50 · FY2011 · AG · contact PI
CLINICAL CORE$648,079
P50 · FY2010 · AG · contact PI
CORE--CLINICAL CORE$744,179
P50 · FY2009 · AG · contact PI
CORE--CLINICAL CORE$709,812
P50 · FY2008 · AG · contact PI
CORE--CLINICAL CORE$726,984
P50 · FY2007 · AG · contact PI
CORE--CLINICAL CORE$393,446
P50 · FY2006 · AG · contact PI
CORE--CLINICAL CORE$369,138
P50 · FY2005 · AG
THE CLINICAL CORE - ALZHEIMER'S DISEASE RESEARCH CENTER$21,935
M01 · FY2005 · RR
NITRIC OXIDE IN RENAL DISEASE$248,000
R01 · FY2000 · DK
NITRIC OXIDE IN RENAL DISEASE$14,877
R01 · FY2000 · DK